MHRA-100209-PIP01-21-M01 (update)

Key Facts

Active Substance
Active Substance:
  • Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain
Invented Name
Not available at present
PIP Number MHRA-100209-PIP01-21-M01 (update)
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Gastroenterology-Hepatology
Conditions / Indications
Conditions / Indications:
  • Treatment of obesity
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
PM: decision on the application for modification of an agreed paediatric investigation plan.
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain.pdf
Published Date 24/06/2024